Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and men... 85 KB (8,561 words) - 07:12, 15 January 2024 |
N-Desmethyltamoxifen (redirect from Nor-tamoxifen) N-Desmethyltamoxifen (developmental code name ICI-55,548) is a major metabolite of tamoxifen, a selective estrogen receptor modulator (SERM). N-Desmethyltamoxifen... 4 KB (244 words) - 22:33, 5 March 2022 |
Tamoxifen and Raloxifene (STAR) is a clinical trial from the early 2000s designed determine how the drug raloxifene compares with the drug tamoxifen in... 3 KB (222 words) - 21:00, 20 December 2023 |
Letrozole (section Comparison with tamoxifen) receptor positive or has an unknown receptor status in postmenopausal women. Tamoxifen is also used to treat hormonally-responsive breast cancer, but it does... 20 KB (1,843 words) - 22:03, 7 April 2024 |
positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years... 18 KB (1,764 words) - 00:25, 4 April 2024 |
Antiestrogen withdrawal response (redirect from Tamoxifen withdrawal response) documented rarely with the selective estrogen receptor modulators (SERMs) tamoxifen and raloxifene. The phenomenon indicates that these agents can somehow... 3 KB (293 words) - 22:58, 13 December 2023 |
Further, these knockouts can be inducible. In several mouse studies, tamoxifen is used to induce the Cre recombinase. In this case, Cre recombinase is... 12 KB (1,436 words) - 07:02, 22 February 2024 |
AFPep (section Combination therapy with tamoxifen) toxicities of tamoxifen. Tamoxifen has been a very effective drug for the treatment of estrogen receptor-positive breast cancer. But tamoxifen has certain... 9 KB (1,078 words) - 15:55, 21 November 2023 |
recombinase, resulting in Cre becoming specifically activated by tamoxifen. In the absence of tamoxifen, CreER will result in the shuttling of the mutated recombinase... 40 KB (5,058 words) - 07:42, 8 May 2024 |
Antiestrogens include selective estrogen receptor modulators (SERMs) like tamoxifen, clomifene, and raloxifene, the ER silent antagonist and selective estrogen... 9 KB (803 words) - 11:32, 4 January 2024 |
Antihormone therapy (section Tamoxifen and Toremifene) Metastatic breast cancer, tamoxifen can be prescribed to selectively block estrogen's effect on certain cells. SERMs like tamoxifen attach to receptors on... 11 KB (1,108 words) - 06:33, 12 October 2023 |
gefitinib-resistant NSCLC cell lines. In breast cancer, the acquisition of tamoxifen resistance is another major therapeutic problem. It has been shown that... 18 KB (2,105 words) - 17:15, 1 December 2023 |
Introduction of laser therapy in treatment of cancer 1960 – Invention of tamoxifen breast cancer anti-estrogen (SERM) hormonal therapy drug 1961 – Vincristine... 27 KB (2,580 words) - 18:15, 7 September 2023 |
therapy in oncology is the use of the selective estrogen-response modulator tamoxifen for the treatment of breast cancer, although another class of hormonal... 12 KB (1,371 words) - 12:19, 4 April 2024 |
taking pills that contain estrogen without progesterone, a history of tamoxifen use, late menopause, and a family history of the condition. Risk factors... 25 KB (2,040 words) - 19:25, 5 March 2024 |
genistein, miroestrol) Selective estrogen receptor modulators (e.g., tamoxifen, clomifene, raloxifene) Antiestrogens (e.g., fulvestrant, ICI-164384,... 34 KB (3,816 words) - 15:00, 31 January 2024 |
Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria... 6 KB (362 words) - 05:53, 24 March 2024 |
Ovulation induction (section Tamoxifen) Medications in use for this effect are mainly clomifene citrate and tamoxifen (both being selective estrogen-receptor modulators), as well as letrozole... 30 KB (3,249 words) - 12:55, 2 April 2024 |